Product NDC: | 51224-154 |
Proprietary Name: | Flavoxate Hydrochloride |
Non Proprietary Name: | Flavoxate hydrochloride |
Active Ingredient(s): | 100 mg/1 & nbsp; Flavoxate hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51224-154 |
Labeler Name: | TAGI Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076835 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110325 |
Package NDC: | 51224-154-50 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (51224-154-50) |
NDC Code | 51224-154-50 |
Proprietary Name | Flavoxate Hydrochloride |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (51224-154-50) |
Product NDC | 51224-154 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Flavoxate hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110325 |
Marketing Category Name | ANDA |
Labeler Name | TAGI Pharma, Inc. |
Substance Name | FLAVOXATE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |